Freedman R, Subramanian M. Effects of symptomatic status and the menstrual cycle on hot ﬂash-related thermoregulatory parameters. Menopause 2005;12:156–159.
7.
Kronenberg F, Barnard RM. Modulation of menopausal hot ﬂashes by ambient temperature. J Therm Biol 1992;17:43–49.
8.
Gold E, Sternfeld B, Kelsey J, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000;152:463– 473.
9.
Whiteman M, Staropoli C, Langenberg P, et al. Smoking, body mass, and hot ﬂashes in midlife women. Obstet Gynecol 2003;101:264–272.
10.
Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805–813.
11.
Krebs E, Ensrud K, MacDonald R, et al. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004;104:824–836.
12.
Newton K, Reed S, LaCroix A, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo. Ann Intern Med 2006;145:869–879.
13.
Barton D, Loprinzi C, Quella S, et al. Prospective evaluation of vitamin E for hot ﬂashes in breast cancer survivors. J Clin Oncol 1998;16:495–500.
14.
Avis N, Legault C, Coeytaux R, et al. A randomized, controlled pilot study of acupuncture treatment for menopausal hot ﬂashes. Menopause 2008;15:1070–1078.
15.
Utian WH, Shoupe D, Bachmann G, et al. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065– 1078.
16.
Notelovitz M, Lenihan J, McDermott M, et al. Initial 17B-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000;95:726– 731.
17.
Bachmann G, Schaefers M, Uddin A, et al. Lowest effective trans-dermal 17b-estradiol dose for relief of hot ﬂushes in postmenopausal women. Obstet Gynecol 2007;110:771–779.
18.
North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004;11:11–33.
19.
Schiff I, Tulchinsky D, Cramer D, et al. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA 1980;244:1443– 1445.
20.